^
Association details:
| Biomarker: | TMB-L |
|---|---|
| Cancer: | Glioblastoma |
| Drug Class: | PD1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
214 The effect of Anti-PD-1 therapy on median overall survival and progression free survival in glioblastoma multiforme patients with certain tumor markers
Published date:
11/09/2020
Excerpt:
Upon analyzing the data the presence of a TERT promoter 124C>T mutation, IDH wildtype, and lower TMB gave much better OS and PFS after treatment in patients on Anti-PD1 therapy.
DOI:
10.1136/jitc-2020-SITC2020.0214
